Trump Admin and RFK Jr. Halt Funding for mRNA Vaccine Development

The Trump administration is withdrawing $500 million in funding for new mRNA vaccine development to focus on broader, safer vaccine platforms, citing concerns about vaccine effectiveness against respiratory infections like COVID and flu. This move includes canceling contracts with Moderna, Pfizer, and Sanofi Pasteur, raising concerns among experts about potential vulnerabilities and the impact on biodefense capabilities. The decision reflects a shift in vaccine policy under RFK Jr., amid ongoing debates about vaccine efficacy and safety.